MT
Mangrove Therapeutics Inc.
SEC filingBiotechnology · Sacramento, CA
Amount raised$2.5Msold at filing
Total offering$5M$2.5M still open
Investors in the raise9count reported to the SEC
FiledJul 31, 2026first sale Jul 21, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jin LiDirector
Benjamin Zhiyi ChenExecutive Officer, Director
Alexander Simon GreenExecutive Officer
Executive officers, directors and promoters as listed on the Form D.